1. Home
  2. CLDX vs VZLA Comparison

CLDX vs VZLA Comparison

Compare CLDX & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • VZLA
  • Stock Information
  • Founded
  • CLDX N/A
  • VZLA 2017
  • Country
  • CLDX United States
  • VZLA Canada
  • Employees
  • CLDX N/A
  • VZLA N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • VZLA
  • Sector
  • CLDX Health Care
  • VZLA
  • Exchange
  • CLDX Nasdaq
  • VZLA Nasdaq
  • Market Cap
  • CLDX 1.4B
  • VZLA 1.1B
  • IPO Year
  • CLDX 2008
  • VZLA N/A
  • Fundamental
  • Price
  • CLDX $22.08
  • VZLA $3.67
  • Analyst Decision
  • CLDX Strong Buy
  • VZLA Strong Buy
  • Analyst Count
  • CLDX 9
  • VZLA 1
  • Target Price
  • CLDX $46.13
  • VZLA $3.25
  • AVG Volume (30 Days)
  • CLDX 1.5M
  • VZLA 3.3M
  • Earning Date
  • CLDX 08-07-2025
  • VZLA 09-08-2025
  • Dividend Yield
  • CLDX N/A
  • VZLA N/A
  • EPS Growth
  • CLDX N/A
  • VZLA N/A
  • EPS
  • CLDX N/A
  • VZLA N/A
  • Revenue
  • CLDX $5,790,000.00
  • VZLA N/A
  • Revenue This Year
  • CLDX N/A
  • VZLA N/A
  • Revenue Next Year
  • CLDX N/A
  • VZLA N/A
  • P/E Ratio
  • CLDX N/A
  • VZLA N/A
  • Revenue Growth
  • CLDX N/A
  • VZLA N/A
  • 52 Week Low
  • CLDX $14.40
  • VZLA $1.67
  • 52 Week High
  • CLDX $47.00
  • VZLA $3.70
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 47.99
  • VZLA 65.56
  • Support Level
  • CLDX $21.34
  • VZLA $3.38
  • Resistance Level
  • CLDX $23.27
  • VZLA $3.59
  • Average True Range (ATR)
  • CLDX 1.54
  • VZLA 0.14
  • MACD
  • CLDX -0.15
  • VZLA 0.02
  • Stochastic Oscillator
  • CLDX 33.75
  • VZLA 92.55

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

Share on Social Networks: